Soland Daniel B
- SEC CIK
- 0001318485
No open-market purchases or sales filed in the past year.
Current role at each company
- ACAD Acadia Pharmaceuticals IncDirectoras of Jun 2, 2025
- DBVT DBV Technologies S.A.Directoras of Aug 3, 2023
- ACGN Aceragen, Inc.CHIEF OPERATING OFFICERas of Jul 7, 2022
- KALV KalVista Pharmaceuticals, Inc.Directoras of Oct 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Soland Daniel B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DBVT DBV Technologies S.A.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 (view filing) | Aug 1 | 2 days | Soland Daniel BDirector | PPurchase | +15.0K | $1.62 | +$24.3K | +300.0%20.0K after |